CARIS LIFE SCIENCES, INC. Net Income (Loss) Available to Common Stockholders, Basic
CARIS LIFE SCIENCES, INC. (CAI) reported Net Income (Loss) Available to Common Stockholders, Basic of -$637.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-08-05
- CARIS LIFE SCIENCES, INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was -$637.00K.
- CARIS LIFE SCIENCES, INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was -$510.00K.
- CARIS LIFE SCIENCES, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-12-31 was $81.96M.
- CARIS LIFE SCIENCES, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was $24.32M.
- CARIS LIFE SCIENCES, INC. net income (loss) available to common stockholders, basic for fiscal 2025 was -$537.96M.
- CARIS LIFE SCIENCES, INC. net income (loss) available to common stockholders, basic for fiscal 2024 was -$378.26M.
- CARIS LIFE SCIENCES, INC. net income (loss) available to common stockholders, basic for fiscal 2023 was -$462.53M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$637.00K 10-Q · filed 2026-08-05 | -$1.15M 10-Q · filed 2026-08-05 | $80.81M derived: sum of 3 quarters · filed 2026-08-05 | $105.14M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$510.00K 10-Q · filed 2026-05-08 | $81.45M derived: sum of 2 quarters · filed 2026-05-08 | $105.77M derived: sum of 3 quarters · filed 2026-05-08 | -$411.43M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $81.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $106.28M derived: sum of 2 quarters · filed 2026-03-03 | -$410.92M derived: sum of 3 quarters · filed 2026-08-05 | -$537.96M 10-K · filed 2026-03-03 |
| 2025-09-30 | $24.32M 10-Q · filed 2025-11-05 | -$492.87M derived: sum of 2 quarters · filed 2026-08-05 | -$619.91M 10-Q · filed 2025-11-05 | -$681.86M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$517.20M 10-Q · filed 2026-08-05 | -$644.24M 10-Q · filed 2026-08-05 | -$706.19M derived: sum of 3 quarters · filed 2026-08-05 | -$798.58M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$127.04M 10-Q · filed 2026-05-08 | -$188.99M derived: sum of 2 quarters · filed 2026-05-08 | -$281.38M derived: sum of 3 quarters · filed 2026-05-08 | -$371.16M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$61.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$154.34M derived: sum of 2 quarters · filed 2026-03-03 | -$244.12M derived: sum of 3 quarters · filed 2026-03-03 | -$378.26M 10-K · filed 2026-03-03 |
| 2024-09-30 | -$92.39M 10-Q · filed 2025-11-05 | -$182.17M derived: sum of 2 quarters · filed 2025-11-05 | -$316.31M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | -$89.78M 10-Q · filed 2025-08-12 | -$223.92M 10-Q · filed 2025-08-12 | ||
| 2023-12-31 | -$462.53M 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |